SA JOURNAL OF DIABETES & VASCULAR DISEASE
ACHIEVING BEST PRACTICE
VOLUME 7 NUMBER 2 • JUNE 2010
79
asymptomatic men.
Circulation
1980;
62
: 1196–203.
Yeung AC, Barry J, Orav J,
9.
et al
. Effect of asymptomatic ischaemia on long-term
prognosis in chronic stable coronary disease.
Circulation
1991;
83
: 1598–604.
Fazzini PF, Prati PL, Rovelli F,
10.
et al
. Epidemiology of silent myocardial ischaemia
in asymptomatic middle-aged men (the eccis project).
Am J Cardiol
1993;
72
:
1383–8.
Froehicher VF, Thompson AJ, Longo MR Jr,
11.
et al
. Value of exercise testing for
screening asymptomatic men for latent coronary artery disease.
Prog Cardiovasc
Dis
1976;
18
: 265–76.
Thaulow E, Erikssen J, Sandik L,
12.
et al
. Initial clinical presentation of cardiac disease
in asymptomatic men with silent myocardial ischaemia and angiographically
documented coronary artery disease: the Oslo ischemic study.
Am J Cardiol
1993;
72
: 629–33.
He ZX, Hedrick TD, Pratt CM
13.
, et al.
Severity of coronary artery calcification by
electron beam computed tomograpgy predicts silent myocardial ischaemia.
Circulation
2000;
10
: 244–51.
Laukkanen JA, Kurl S, Lakka TA,
14.
et al
. Exercise-induced silent myocardial
ischaemia and coronary morbidity and mortality in middle aged men.
J Am Coll
Cardiol
2001;
38
: 72–9.
Langer A, Freeman MR, Josse RG,
15.
et al
. Detection of silent myocardial ischaemia
in diabetes mellitus.
Am J Cardiol
1991;
67
: 1073–8.
Naka M, Hiramatsu K, Aizawa T,
16.
et al
. Silent myocardial ischaemia in patients
with non-insulin-dependent diabetes mellitus as judged by treadmill exercise
testing and coronary angiography.
Am Heart J
1992;
123
: 46–53.
Scognamiglio R, Negut C, Ramondo A,
17.
et al
. Detection of coronary artery disease
in asymptomatic patients with type 2 diabetes mellitus.
J Am Coll Cardiol
2006;
47
: 65.
Multiple risk factor intervention trial research group. Exercise electrocardiogram
18.
and coronary heart disease mortality in the multiple risk factor intervention trial.
Am J Cardiol
1985;
55
: 16–24.
Rutter MK, Wahid ST, McComb JM, Marshall SM. Significance of silent ischemia
19.
and microalbuminaemia in predicting coronary events in asymptomatic patients
with type 2 diabetes mellitus.
J Am Coll Cardiol
2002;
40
: 56–61.
Deedwania P, Carbajal EV. Silent ischemia during daily life is an independent
20.
predictor of mortality in stable angina.
Circulation
1990;
81
: 748–56.
Deedwania P, Carbajal EV. Prevalence and patterns of silent myocardial ischemia
21.
during daily life instable angina patients receiving conventional antianginal drug
therapy.
Am J Cardiol
1990;
65
: 1090–6.
Forslund L, Hjemdahl P, Held C,
22.
et al
. Prognostic implications of ambulatory
myocardial ischemia and arrhythmias and relation to ischemia on exercise in
chronic stable angina pectoris (the Angina Prognosis Study in Stockholm [apsis]).
Am J Cardiol
1999;
84
: 1151–7.
Deedwania PC. Asymptomatic ischemia during pre-discharge Holter monitoring
23.
predicts poor prognosis in the post infarction period.
Am J Cardiol
1993;
71
:
773–7.
Nairns CR, Zareba W, Moss AJ,
24.
et al
. Clinical implications of silent versus
symptomatic exercise-induced myocardial ischaemia in patients with stable
coronary disease.
J Am Coll Cardiol
1997;
29
: 756–63.
Nørgaard BL, Andersen K, Dellborg M,
25.
et al
. The trim study group. Admission risk
assessment by cardiac troponin T in unstable coronary artery disease: additional
prognostic information from continuous ST segment monitoring.
J Am Coll
Cardiol
1999;
33
: 1519–27.
Geft I, Fischbein M, Ninomiya K. Intermittent brief episodes of ischaemia have
26.
a cumulative effect and may cause myocardial necrosis.
Circulation
1982;
66
:
1150–3.
Schaper J. Effects of multiple ischaemic events on human myocardium: an
27.
ultrastructural study.
Eur Heart J
1988;
9
(suppl a): 141–9.
Mulcahy D, Keegan J, Sparrow J,
28.
et al
. Iscahemia in the ambulatory setting:
the total ischaemic burden: relation to exercise testing and investigative and
therapeutic implications.
J Am Coll Cardiol
1989;
14
: 1166–72.
Deedwania PC. Should asymptomatic subjects with silent ischaemia undergo
29.
further evaluation and follow up?
Int J Cardiol
1994;
44
: 101–3.
Cheitlin MD, Armstrong WF, Aurigemma GP,
30.
et al
. Acc/aha/ase 2003 guideline
update for the clinical application of echocardiography: summary article: a report
of the American College of Cardiology/American Heart Association Task Force on
Practice Guidelines.
J Am Coll Cardiol
2003;
42
: 954–70.
Rumberger JA, Sheedy PF, Breen JF,
31.
et al
. Electron beam computed tomographic
coronary calcium score cut points and severity of associated angiographic lumen
stenosis.
J Am Coll Cardiol
1997;
29
: 1542–8.
He Z, Hedrick T, Pratt C. Severity of coronary artery calcification by electron beam
32.
computed tomography predicts silent myocardial ischaemia.
Circulation
2000;
101
: 244–51.
Wackers F, Chyun D, Young L,
33.
et al
. Resolution of asymptomatic myocardial
iscemia in patients with type 2 diabetes in the detection of ischemia in
asymptomatic diabetics (DIAD-2).
Diabetes Care
2007;
30
: 2892–8.
National Institute for Health and Clinical Excellence. Lipid modification.
34.
Cardiovascular risk assessment and modification of blood lipids for the primary
and secondary prevention of cardiovascular disease. NICE clinical guideline.
London: NICE, 2008.
National Institue for Health and Clinical Excellence. Type 2 diabetes. The
35.
management of type 2 diabets. NICE clinical guideline. London: NICE, 2008.
Colhoun HM, Betteridge DJ, Durrington PN,
36.
et al
. Cards investigators. Primary
prevention of cardiovascular disease with atorvastatin in type 2 diabetes in
the collaborative atorvastatin diabetes study (cards): multicentre randomised
placebo-controlled trial.
Lancet
2004;
364
: 685–96.
Sorajja P, Chareonthaitawee P, Rajagopalan N,
37.
et al
. Improved survival in
asymptomatic diabetic patients with high risk spect imaging treated with
coronary artery bypass grafting.
Circulation
2005;
112
: 1311–6.
The
38.
Bari investigators. Influence of diabetes on 5-year mortality and morbidity
in a randomized trial comparing cabg and ptca in patients with multi-vessel
disease: the bypass angioplasty revascularisation investigation.
Circulation
1997;
96
: 1761–9.
Rogers W, Bourassa M, Andrews T,
39.
et al
. Asymptomatic Cardiac Ischemia Pilot
study; outcome at 1 year for patients with ischemia randomised to medical
therapy or revascularisation.
J Am Coll Cardiol
1995;
26
: 594–605.
Bourassa MG, Pepine CJ, Forman SA,
40.
et al
. Aysmptomatc Cardiac Ischemia Pilot
(acip) study: effects of coronary angioplasty and coronary artery bypass surgery
on recurrent angina and ischemia.
J Am Coll Cardiol
1995;
26
: 606–14.
Davies RF, Goldberg D, Forman S,
41.
et al
. The acip investigators. Asymptomatic
Cardiac Ischemia Pilot (acip) study two-year follow up. Outcomes of patients
randomised to initial strategies of medical therapy versus revascularisation.
Circulation
1997;
95
: 2037–43.
Boden WE, O’Rourke RA, Teo KK. Optimal medical therapy with or without PCI
42.
for stable coronary disease.
N Engl J Med
2007;
356
: 1503–16.
Madsen JK, Grande P, Saunamaki K,
43.
et al
. On behalf of the danami study group.
Danish multicentre randomised study of invasive versus conservative treatment
in patients with inducible ischaemia after thrombolysis in acute myocardial
infarction (danami).
Circulation
1997;
96
: 748–55.
Pepine CJ, Cohn PF, Deedwania PC,
44.
et al
. Effects of treatment on outcome in
mildly symptomatic patients with ischaemia during daily life. The atenolol silent
ischaemia study.
Circulation
1994;
90
: 762–8.
Von Arnim T. The
45.
tibbs investigators. Prognostic significance of transient
ischemic episodes: Response to treatment shows improved prognosis. Results of
the Total Ischemic Burden Bisoprolol Study (tibbs) follow-up.
J Am Coll Cardiol
1996;
28
: 20–4.
American Diabetes Association. Standards of medical care in diabetes 2008.
46.
Diabetes Care
2008;
31
(suppl 1): s12–54.
Zellweger MJ, Hachamovitch R, Kang X,
47.
et al
. Prognostic relevance of symptoms
versus objective evidence of coronary artery disease in diabetic patients.
Eur Heart
J
2004;
25
: 543–50.
Rajagopalan N, Miller TD, Hodge DO,
48.
et al
. Identifying high-risk asymptomatic
diabetic patients who are candidates for screening stress single photon emission
computed tomography imaging.
J Am Coll Cardiol
2005;
45
: 43–9.
Nesto PW, Watson FS, Kowalchuk GJ,
49.
et al
. Silent myocardial ischemia and
infarction in diabetics with peripheral vascular disease: assessment by dipyridamole
thallium-201 scintigraphy.
Am Heart J
1990;
120
: 1073–7.
Belch JJF, Topol EJ, Agnelli G,
50.
et al
. Critical issues in peripheral arterial disease
detection and management: a call to action.
Arch Intern Med
2003;
163
: 884–
92.
Hertzer NR, Beven EG, Young JR,
51.
et al
. Coronary artery disease in peripheral
vascular patients: a classification of 1000 coronary angiograms and results of
surgical management.
Ann Surg
1984;
199
: 223–33.
Vinik AI, Maser RE, Mitchell BD. Diabetic autonomic neuropathy.
52.
Diabetes Care
2003;
26
: 1553–79.
O’Sullivan JJ, Conroy RM, MacDonald K,
53.
et al
. Silent ischaemia in diabetic men
with autonomic neuropathy.
Br Heart J
1991;
66
: 313–5.
Niakan E, Harati Y, Rolak LA,
54.
et al
. Silent myocardial infarction and diabetic
cardiovascular autonomic neuropathy.
Arch Intern Med
1986;
146
: 2229–30.
Ma RC, So WY, Yang X,
55.
et al
. Erectile dysfunction predicts coronary heart disease
in type 2 diabetics.
J Am Coll Cardiol
2008;
51
: 2045–50.
Gazzaruso C, Giordanetti S, De Amici E,
56.
et al
. Relationship between erectile
dysfunction and silent myocardial ischaemia in apparently uncomplicated type 2
diabetic patients.
Circulation
2004;
110
: 22–6.
Wackers FJ, Young LH, Inzucchi SE,
57.
et al
. Detection of silent myocardial ischaemia
in asymptomatic diabetic subjects.
Diabetes Care
2004;
27
: 1954–61.
Rana BS, Davies JI, Band MM,
58.
et al
. B-type natriuretic peptide can detect silent
myocardial ischaemia in asymptomatic type 2 diabetes.
Heart
2006;
92
: 916–
20.
